Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 522 clinical trials
Assessing the PrEP Care Cascade Among Black Men and Transwomen in the Southeastern US

The proposed research aims to assess the multiple forms and paths of stigma and substance use as they relate to pre-exposure prophylaxis (PrEP) use for HIV prevention. How stigma and an evolving public health landscape impact PrEP use among Black sexual minorit men who use substances is unknown. The current …

Accepts healthy volunteers
HIV Vaccine
pre-exposure prophylaxis (prep)
  • 0 views
  • 23 Mar, 2022
  • 1 location
Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

sexually transmitted infection (STI) prevention curriculum will reduce rates of short-term repeat infection by improving adherence to PID treatment and reducing unprotected intercourse and be more cost

  • 1 views
  • 22 Mar, 2022
  • 1 location
Addressing Heavy Alcohol Use Consumption With Kudzu (A-HACK)

Drinking multiple alcoholic drinks on a single occasion (binge drinking), has many negative health risks but interventions to address this behavior remain limited. This double-blind, placebo-controlled randomized clinical trial will test whether kudzu, an herbal supplement, can reduce heavy alcohol use and alcohol-associated sexual behaviors among sexually-active, binge-drinking individuals at …

antibody response
drug abuse
heavy drinking
Accepts healthy volunteers
HIV Infection
  • 64 views
  • 04 Oct, 2022
  • 1 location
TAKE Steps: Motivational Interviewing to Improve Comprehensive HIV and Sexually Transmitted Infection Prevention in Adolescent Primary Care (TAKE Steps)

This study will consist of a randomized controlled trial of a motivational interviewing intervention for adolescents with diagnosed sexually transmitted infections (STIs). The sessions will

  • 0 views
  • 10 Oct, 2022
Appalachian Partnership to Reduce Disparities (Aim 2)

By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care

Accepts healthy volunteers
  • 0 views
  • 17 May, 2022
  • 1 location
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention (PCORI PrEP)

The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent …

Accepts healthy volunteers
HIV Vaccine
pre-exposure prophylaxis (prep)
  • 0 views
  • 12 Oct, 2022
  • 3 locations
Sexual and Reproductive Health (Including PrEP and HBV) for Female Sex Workers in Côte d'Ivoire (ANRS 12381)

, prevention and treatment for HIV, viral hepatitis B, sexually transmitted infections and family planning. All services will be available in mobiles clinics operating on prostitution sites and organized for a

Accepts healthy volunteers
hepatitis
sexually transmitted diseases
HIV Vaccine
antiretroviral
  • 1 views
  • 15 Jun, 2022
  • 1 location
Individualized Assessment and Treatment for TMD (TMD3c)

) will be randomized to receive standard care (STD) + an individualized assessment and treatment program (IATP) or to standard care + conventional cognitive-behavioral treatment (STD+CBT). It is expected

headache
chronic pain
  • 0 views
  • 23 Mar, 2022
  • 1 location
A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)

The aim of this study is to improve the chance of cure for people with higher risk Hodgkin lymphoma. The purpose of the Phase I study is to test any good and bad effects of the study drug called Nivolumab when combined with ABVD for the front-line treatment of HL.The …

classical hodgkin lymphoma
avid
doxorubicin
vinblastine
nivolumab
  • 51 views
  • 25 Mar, 2022
  • 10 locations
Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

The STI-6129-001 study is a three-stage, multicenter, open-label, dose-finding, phase 1b/2a trial. It is designed primarily to identify the recommended phase 2 dose (RP2D) of STI-6129 by

  • 0 views
  • 07 Oct, 2022
  • 4 locations